AcuLive’s mission is to generate new therapeutic modalities for the treatment of liver diseases ranging from acute liver failure to NASH. To achieve this we are synthesizing liver cell types using advanced forward reprogramming genetic approaches in combination with innovative material biology methods to encapsulate cells and tissues for optimal therapeutic delivery.
Company Details
- Employees
- 1
- Founded
- 2022
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.aculivetx.com
- Keywords
- Purespring Therapeutics.
Aculive Therapeutics Ltd Questions
Aculive Therapeutics Ltd's website is http://www.aculivetx.com
Aculive Therapeutics Ltd's LinkedIn profile is https://www.linkedin.com/company/aculive-therapeutics-ltd
Aculive Therapeutics Ltd has
1 employees.
View email and phone details for 1
employees at Aculive Therapeutics Ltd.
Aculive Therapeutics Ltd's industry is
Biotechnology Research
Aculive Therapeutics Ltd's top competitors are
Bit.bio,
Borussia Vfl 1900 Mönchengladbach Gmbh,
Wellcome Sanger Institute,
Purespring Therapeutics,
Ascendbio Ltd,
Berlin Institute Of Health,
O2h Ventures,
Definigen,
Syd™ Life Ai,
Oxgene.
Aculive Therapeutics Ltd's categories are Biotechnology Research
Aculive Therapeutics Ltd's founding year is 2022
